Daskal Ilan's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Sep 3, 2021
- Accession no.
- 0001062993-21-008242
- Filed
- Sep 3, 2021
- Trade date
- Sep 1-2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $447.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Daskal IlanCIK 0001446964 | Officer (EVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +540 | $524.30 | +$283,122 | 547 | Direct | |
| Sep 2, 2021 | Bio-Rad A Common Stock | SSaleDisposed | −440 | $828.00 | −$364,320 | 107 | Direct | |
| Sep 2, 2021 | Bio-Rad A Common Stock | SSaleDisposed | −100 | $828.01 | −$82,801 | 7 | Direct | |
| Sep 2, 2021 | Bio-Rad A Common Stock | MOption exerciseAcquired | +541 | $0.00 | $0 | 548 | Direct | |
| Sep 2, 2021 | Bio-Rad A Common Stock | FTax withholdingDisposed | −269 | $825.77 | −$222,132.13 | 279 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Bio-Rad A Common Stock | AGrant or awardAcquired | +1,823 | $0.00 | $0 | 1,823 | Direct | |
| Sep 1, 2021 | Bio-Rad A Common Stock | AGrant or awardAcquired | +1,823 | $0.00 | $0 | 1,823 | Direct | |
| Sep 2, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −540 | $0.00 | $0 | 1,626 | Direct | |
| Sep 2, 2021 | Bio-Rad A Common Stock | MOption exerciseDisposed | −541 | $0.00 | $0 | 1,625 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.